Correlation Between Achilles Therapeutics and Unicycive Therapeutics
Can any of the company-specific risk be diversified away by investing in both Achilles Therapeutics and Unicycive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Achilles Therapeutics and Unicycive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Achilles Therapeutics PLC and Unicycive Therapeutics, you can compare the effects of market volatilities on Achilles Therapeutics and Unicycive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Achilles Therapeutics with a short position of Unicycive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Achilles Therapeutics and Unicycive Therapeutics.
Diversification Opportunities for Achilles Therapeutics and Unicycive Therapeutics
0.64 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Achilles and Unicycive is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Achilles Therapeutics PLC and Unicycive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Unicycive Therapeutics and Achilles Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Achilles Therapeutics PLC are associated (or correlated) with Unicycive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Unicycive Therapeutics has no effect on the direction of Achilles Therapeutics i.e., Achilles Therapeutics and Unicycive Therapeutics go up and down completely randomly.
Pair Corralation between Achilles Therapeutics and Unicycive Therapeutics
Given the investment horizon of 90 days Achilles Therapeutics PLC is expected to generate 0.52 times more return on investment than Unicycive Therapeutics. However, Achilles Therapeutics PLC is 1.91 times less risky than Unicycive Therapeutics. It trades about 0.08 of its potential returns per unit of risk. Unicycive Therapeutics is currently generating about -0.02 per unit of risk. If you would invest 86.00 in Achilles Therapeutics PLC on June 24, 2024 and sell it today you would earn a total of 18.00 from holding Achilles Therapeutics PLC or generate 20.93% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Achilles Therapeutics PLC vs. Unicycive Therapeutics
Performance |
Timeline |
Achilles Therapeutics PLC |
Unicycive Therapeutics |
Achilles Therapeutics and Unicycive Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Achilles Therapeutics and Unicycive Therapeutics
The main advantage of trading using opposite Achilles Therapeutics and Unicycive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Achilles Therapeutics position performs unexpectedly, Unicycive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Unicycive Therapeutics will offset losses from the drop in Unicycive Therapeutics' long position.Achilles Therapeutics vs. HCW Biologics | Achilles Therapeutics vs. RenovoRx | Achilles Therapeutics vs. Scpharmaceuticals | Achilles Therapeutics vs. Milestone Pharmaceuticals |
Unicycive Therapeutics vs. HCW Biologics | Unicycive Therapeutics vs. RenovoRx | Unicycive Therapeutics vs. Scpharmaceuticals | Unicycive Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |